Camsing Healthcare Limited

As of July 31, 2026, Camsing Healthcare Limited carries a market capitalization of 9.66M, placing it among publicly traded companies globally. Its enterprise value stands at 14.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of July 31, 2026, Camsing Healthcare Limited has 140.00M shares outstanding.

These figures are as of July 31, 2026. The price-to-sales ratio is 1.98, and the price-to-book ratio stands at -1.44.

These figures are as of July 31, 2026. The EV/Sales ratio of 3.95 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 14.08M versus a market cap of 9.66M, with the gap driven by net debt and cash on the balance sheet.

As of July 31, 2026, Camsing Healthcare Limited maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -66.38, indicating conservative leverage, while an interest coverage ratio of -14.47 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended July 31, 2026. Return on assets (ROA) is negative at -118.31, reflecting losses generated across the asset base. Inventory turnover of 4.90 indicates how many times Camsing Healthcare Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Camsing Healthcare Limited's stock has gained approximately 176.74% over the past 52 weeks.

Over the twelve months ended July 31, 2026, Camsing Healthcare Limited generated 3.57M in revenue and converted that into -1.02M in net income, yielding earnings per share of -0.01. EBITDA reached -1.29M, while operating income came in at -1.43M.

As of July 31, 2026, Camsing Healthcare Limited holds 44,000.00 in cash and equivalents against 4.46M in total debt, resulting in a net debt position of 4.07M. Total book value stands at -6.72M, with working capital of -4.93M providing operational flexibility.

Camsing Healthcare Limited produced -664,000.00 in operating cash flow over the twelve months ended July 31, 2026. After subtracting -24,000.00 in capital expenditures, free cash flow totaled -688,000.00 - equivalent to -0.01 per share.

Over the twelve months ended July 31, 2026, Camsing Healthcare Limited posted a gross margin of 54.13, reflecting its pricing power and cost economics. The operating margin of -39.96 and net profit margin of -28.69 provide insight into operational efficiency.

These figures cover the twelve months ended July 31, 2026. Free cash flow yield is negative at -9.74: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -7.18, meaning Camsing Healthcare Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Camsing Healthcare Limited's most recent stock split took place on June 19, 2015 with a 5:1 split ratio.

As of July 31, 2026, Camsing Healthcare Limited has an Altman Z-Score of -56.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.